These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9303591)

  • 1. [Antinuclear antibodies in multiple sclerosis].
    Antigüedad A; Ruiz J; Mendibe MM; Zarranz JJ
    Neurologia; 1997; 12(6):245-8. PubMed ID: 9303591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases.
    Marin GG; Cardiel MH; Cornejo H; Viveros ME
    J Clin Rheumatol; 2009 Oct; 15(7):325-9. PubMed ID: 20009966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating autoantibodies in multiple sclerosis.
    Tomasević L; Nikolić J; Lukić M; Lević Z
    Neurologija; 1990; 39(3):157-61. PubMed ID: 2290463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The initial manifestations and final diagnosis of patients with high and low titers of antinuclear antibodies after 6 months of follow-up.
    Wang KY; Yang YH; Chuang YH; Chan PJ; Yu HH; Lee JH; Wang LC; Chiang BL
    J Microbiol Immunol Infect; 2011 Jun; 44(3):222-8. PubMed ID: 21524618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and clinical significance of anti-phospholipid antibodies in multiple sclerosis: a study of 89 patients.
    Roussel V; Yi F; Jauberteau MO; Couderq C; Lacombe C; Michelet V; Gil R; Couratier P; Vallat JM; Preud'homme JL
    J Autoimmun; 2000 May; 14(3):259-65. PubMed ID: 10756088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinuclear antibodies in recurrent idiopathic pericarditis: prevalence and clinical significance.
    Imazio M; Brucato A; Doria A; Brambilla G; Ghirardello A; Romito A; Natale G; Palmieri G; Trinchero R; Adler Y
    Int J Cardiol; 2009 Aug; 136(3):289-93. PubMed ID: 18674829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum auto antibodies presence in multiple sclerosis patients treated with beta-interferon 1a and 1b.
    Speciale L; Saresella M; Caputo D; Ruzzante S; Mancuso R; Calvo MG; Guerini FR; Ferrante P
    J Neurovirol; 2000 May; 6 Suppl 2():S57-61. PubMed ID: 10871787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineutrophil cytoplasmic antibody in patients with antinuclear antibody-positive chronic hepatitis C.
    Ohira H; Tojo J; Shinzawa J; Suzuki T; Miyata M; Nishimaki T; Kasukawa R
    Fukushima J Med Sci; 1998 Dec; 44(2):83-92. PubMed ID: 10091380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of antinuclear antibody testing in unexplained second and third trimester fetal deaths.
    Incerpi MH; Banks EH; Goodwein SN; Samadi R; Goodwin TM
    J Matern Fetal Med; 1998; 7(2):61-4. PubMed ID: 9584815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A positive antinuclear antibody test predicts for a poor response to initial steroid therapy in adults with idiopathic thrombocytopenic purpura.
    Abbasi SY; Milhem M; Zaru L
    Ann Hematol; 2008 Jun; 87(6):459-62. PubMed ID: 18265983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune thyroid disease and autoimmune rheumatic disorders: a two-sided analysis.
    Lazúrová I; Benhatchi K; Rovenský J; Kozáková D; Wagnerová H; Tajtáková M; Shoenfeld Y; Macejova Z
    Ann N Y Acad Sci; 2009 Sep; 1173():211-6. PubMed ID: 19758153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased percentages of autoantibodies in immunoglobulin A-deficient children do not correlate with clinical manifestations.
    Gulez N; Karaca NE; Aksu G; Kutukculer N
    Autoimmunity; 2009 Jan; 42(1):74-9. PubMed ID: 19127458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients.
    Garg N; Zivadinov R; Ramanathan M; Vasiliu I; Locke J; Watts K; Lema J; Rajeswary J; Munschauer FE; Ambrus J; Weinstock-Guttman B
    J Neuroimmunol; 2007 Jul; 187(1-2):159-65. PubMed ID: 17512610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases.
    Tektonidou MG; Anapliotou M; Vlachoyiannopoulos P; Moutsopoulos HM
    Ann Rheum Dis; 2004 Sep; 63(9):1159-61. PubMed ID: 15308528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence and significance of positive antinuclear antibodies in patients with fibromyalgia syndrome: 2-4 years' follow-up.
    Al-Allaf AW; Ottewell L; Pullar T
    Clin Rheumatol; 2002 Nov; 21(6):472-7. PubMed ID: 12447630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China.
    Bai L; Feng ZR; Lu HY; Li WG; Yu M; Xu XY
    Chin Med J (Engl); 2009 Jan; 122(1):5-9. PubMed ID: 19187609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is minocycline therapy in acne associated with antineutrophil cytoplasmic antibody positivity? A cross-sectional study.
    Marzo-Ortega H; Baxter K; Strauss RM; Drysdale S; Griffiths B; Misbah SA; Gough A; Cunliffe WJ; Emery P
    Br J Dermatol; 2007 May; 156(5):1005-9. PubMed ID: 17408394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinuclear antibodies in patients with polymorphic light eruption: a long-term follow-up study.
    Tzaneva S; Volc-Platzer B; Kittler H; Hönigsmann H; Tanew A
    Br J Dermatol; 2008 May; 158(5):1050-4. PubMed ID: 18341657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A prospective study on the prevalence and clinical significance of autoantibodies in patients with suspected nonalcoholic fatty liver disease].
    Cho DH; Choi MS; Kim DH; Kim DY; Shim SG; Lee JH; Koh KC; Paik SW; Yoo BC; Rhee JC
    Korean J Hepatol; 2005 Sep; 11(3):261-7. PubMed ID: 16177552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
    Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
    J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.